Close
ThinkAdvisor

Life Health > Health Insurance > Health Insurance

Customers of genetic testing company 23andMe are caught in DNA limbo

X
Your article was successfully shared with the contacts you provided.

There has been little word from 23andMe since the Food and Drug Administration ordered the company to stop marketing its $99 genetic test kit. The company’s CEO issued a blog promising to address the FDA’s concerns, but what does that mean for 23andMe customers who have either received results or are currently waiting for test results?